DNA Print Genomics Total Liabilities

DNA Print Genomics (DNAG) currently reports a total liabilities of $11M as of September 2007. That compares with $10M in the prior-year period — up 10.2% year over year. Use the charts on this page to explore DNA Print Genomics's total liabilities history and peer comparisons.

DNA Print Genomics's total liabilities increased from $10M to $11M — a 10.2% year-over-year increase (period ending September 2007). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DNA Print Genomics reported $11M in total liabilities as of September 2007. That compares with $10M in the prior-year period — up 10.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DNA Print Genomics, and consider following DNAG for alerts when major investors trade the stock.

DNA Print Genomics is classified in the Healthcare sector. On total liabilities, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DNAG with unrelated industries.